Related Experiment Videos
[Vasoactive factors in chronic glomerulonephritis]
V Knotková1, M Havrda, M Jáchymová
1II. interní klinika 1., LF UK a VFN, Praha.
Casopis Lekaru Ceskych
|November 6, 1996
Summary
Chronic glomerulonephritis adaptation changes persist during remission. Increased renal thromboxane, a marker of glomerular changes, can be blocked by acetylsalicylic acid. Decreased atrium natriuretic peptide may indicate tubulointerstitial changes.
Area of Science:
- Nephrology
- Immunopathology
- Renal Physiology
Context:
- Kidney damage in chronic glomerulonephritis involves both immunopathological events and chronic adaptation changes.
- Understanding these adaptation changes is crucial, even during clinical remission.
- Identifying markers for these changes can aid in patient management.
Purpose:
- To identify active agents that serve as markers of ongoing adaptation changes in chronic glomerulonephritis.
- To determine if these adaptation changes are detectable in patients in remission.
- To investigate the role of thromboxane and atrium natriuretic peptide in chronic glomerulonephritis remission.
Summary:
- Measurements of renin activity, atrial natriuretic peptide, endothelin, and urinary prostanoids were performed in 33 patients with stable chronic glomerulonephritis and 21 healthy controls.
- Untreated patients without proteinuria showed significantly higher urinary thromboxane elimination compared to other groups.
- All patients with chronic glomerulonephritis exhibited significantly lower plasma atrial natriuretic peptide levels than healthy individuals.
Impact:
- Adaptation changes continue even in patients with chronic glomerulonephritis in clinical remission.
- Increased renal thromboxane production, a marker of glomerular changes, can be effectively managed with acetylsalicylic acid.
- Reduced atrial natriuretic peptide levels may signify underlying tubulointerstitial changes in chronic glomerulonephritis.